Rheumatoid Arthritis Clinical Trial
— ERAOfficial title:
The Chinese University of Hong Kong Early Arthritis Study
Verified date | July 2012 |
Source | Chinese University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | Hong Kong: Department of Health |
Study type | Interventional |
The purpose of this study is:
1. To ascertain whether the quantitative assessment of enhancing synovial volume and
perfusion indices on serial Magnetic Resonance Imaging (MRI) examination are useful
indicators of responsiveness to treatment in early Rheumatoid Arthritis (RA) using
biologic therapy and Methotrexate (MTX) compared with Methotrexate(MTX) alone.
2. To assess the cost-effectiveness of Tumor Necrosis Factor (TNF) blockers compared with
Methotrexate(MTX) monotherapy for Rheumatoid Arthritis(RA).
Status | Completed |
Enrollment | 40 |
Est. completion date | October 2011 |
Est. primary completion date | October 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Men and women, 18 years of age or older - Clinical diagnosis of RA with a duration not more than 24 months (Fulfilled the 1987 American College of Rheumatology (ACR) criteria for RA) - Patients at risk of developing persistent or erosive arthritis - DAS 28 = 3.2 - Prednisolone < 10mg/day and started at least 4 weeks before baseline - Either has ESR = 28, CRP = 10, presence of rheumatoid factor or anti-CCP, present of HLADRB*0401 or DRB1*0404, and radiographic erosions - Informed consent Exclusion Criteria: - Little or no ability for self-care - Previous treatment with DMARDs other than antimalarials - Concomitant treatment with an experimental drug - Malignancy within the last 5 years - Bone marrow hypoplasia - Clinically significant renal disease ( serum creatinine level = 150µmol/L) or estimated creatinine clearance > 75ml/min, alanine aminotransferase (ALT) exceeds the upper limit of normal - History of any clinically significant adverse reaction to murine or chimeric proteins - History of TB in the last 5 years - Known to have hepatitis B, or hepatitis C - Had an opportunistic infection (e.g. herpes zoster, cytomegalovirus, Pneumocystis carinii, aspergillosis, histoplasmosis, or mycobacteria other than TB) within 6 months before screening - History or ongoing chronic or recurrent disease; renal infection, chest infection, urinary tract infection, ulcer or skin wound - History of infected joint prosthesis and use of antibiotics for the joint - Received intravenous antibiotics within 30 days or oral antibiotics within 14 days for screening - History of known demyelinating diseases (multiple sclerosis or optic neuritis) - Current signs or symptoms of severe diseases (renal, hepatic, hematologic, endocrine, pulmonary, cardiac, neurologic, etc) - History or concurrent CHF - History of lymphoproliferative disease, splenomegaly - Female of childbearing potential, unwilling to use adequate contraception during the study - Current or recent ( within the past 3 months) pregnancy and cancer - Active smoker, alcohol or drug abuse |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | Department of Medicine and Therapeutics | Hong Kong | |
China | Prince of Wales Hospital | Hong Kong | |
China | The Prince of Wales Hospital | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in the volume of enhancing synovitis measured by Magnetic Resonance Imaging(MRI) as it corresponds to active, inflamed tissue and is therefore expected to be a better marker of disease activity. | week 24 | Yes | |
Secondary | changes in the synovitis grading and the perfusion indices | 24 week | Yes | |
Secondary | proportion of patients achieving ACR and EULAR responses | week 24 | Yes | |
Secondary | Correlation between the Magnetic Resonance Imaging(MRI) findings and changes on x-ray | week 24 | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |